Vertex announces UK approval for CASGEVY™
Congratulations to Vertex for their UK approval for CASGEVY™, a CRISPR/Cas9 gene-edited therapy, for...
read Details![Vertex announces UK approval for CASGEVY™](https://www.modality-solutions.com/wp-content/uploads/2023/12/Modality-Resource-Featured-Images-11.png)
Congratulations to Incyte on their FDA approval for Zynyz™, a treatment for adults with metastatic or recurrent locally advanced Merkel cell carcinoma (MCC). Modality Solutions is proud to have been a part of its cold chain strategy!
Congratulations to Vertex for their UK approval for CASGEVY™, a CRISPR/Cas9 gene-edited therapy, for...
read DetailsCongratulations to Melinta Therapeutics for their FDA Approval of REZZAYO™ for the Treatment of...
read DetailsCongratulations to Iveric Bio for their FDA approval for IZERVAY™️️, a new treatment for...
read Details